1 hour ago
3
Prosper Junior Bakiny, The Motley Fool
Tue, May 19, 2026 astatine 6:50 AM CDT 5 min read
We unrecorded successful beauteous volatile times marked by macroeconomic conflicts and worsening inflation, among different things. Equity markets person fared good this twelvemonth contempt these challenges, but it's ever a bully thought to hole for marketplace downturns by investing successful robust companies that tin navigate immoderate environment. One apical banal to see investing successful close present to stabilize a well-diversified portfolio is Johnson & Johnson (NYSE: JNJ), a starring healthcare player. Let's get into wherefore the drugmaker is specified an charismatic prime successful the existent landscape.
Will AI make the world's archetypal trillionaire? Our squad conscionable released a study connected a little-known company, called an "Indispensable Monopoly," providing the captious exertion Nvidia and Intel some need.
It tin upwind each tempest
Several aspects of Johnson & Johnson's concern marque it an outstanding banal to ain during a marketplace crash, an economical downturn, oregon both. Let's see 3 of them. First, Johnson & Johnson sells indispensable products that radical beryllium connected careless of economical conditions, including pharmaceutical drugs and aesculapian devices. No 1 wants to halt taking lifesaving medicines erstwhile the going gets rough. And due to the fact that third-party payers assistance ft overmuch of the measure for patients, galore tin inactive spend to instrumentality their meds erstwhile the purse strings tighten. Demand for the procedures that Johnson & Johnson helps physicians execute with its devices besides tends to stay precocious crossed the economical cycle.
Crucially, Johnson & Johnson is acold much than a emblematic healthcare institution that tin withstand downturns due to the fact that its products stay successful precocious demand. It is 1 of the much diversified players successful the sector. The drugmaker's pharmaceutical portfolio spans respective categories. We tin accidental the aforesaid astir its medtech division. And Johnson & Johnson besides has a heavy pipeline that allows it to people regular brand-new approvals oregon statement expansions. Second, Johnson & Johnson has a rock-solid equilibrium sheet.
Perhaps 1 of the champion pieces of grounds for that is the company's AAA recognition standing from S&P Global. Not lone is it higher than that of the U.S. Government, but it is besides the highest available. So, nary substance the crisis, it's much than apt that Johnson & Johnson volition beryllium capable to instrumentality attraction of its obligations. Third, Johnson & Johnson is simply a Dividend King. Those are companies with 50 (or more) consecutive payout increases -- Johnson & Johnson's streak is astatine 64. This erstwhile again highlights the spot of its underlying business, arsenic paying dividends for that long, fto unsocial raising them each year, is nary casual feat. The regular payouts tin besides assistance mitigate marketplace losses during a downturn.
.png)
English (CA) · 
English (US) · 
Spanish (MX) ·